Elimination of the Native Structure and Solubility of the hVAPB MSP Domain by the Pro56Ser Mutation That Causes Amyotrophic Lateral Sclerosis
- 15 April 2010
- journal article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 49 (18) , 3887-3897
Abstract
The Pro56Ser mutation in the human VAPB MSP domain causes a familial amyotrophic lateral sclerosis. Here we present the first structural investigation of both wild-type and Pro56Ser mutant MSP domains. The results reveal that the wild-type MSP domain is well-folded at neutral pH but can undergo acid-induced unfolding reversibly. It has a thermodynamic stability energy (DeltaG degrees (N-U)) of 7.40 kcal/mol and is also active in binding to a Nir2 peptide with a K(D) of 0.65 muM. Further determination of its crystal structure reveals that it adopts a seven-strand immunoglobulin-like beta sandwich in which Pro56 adopts the unusual cis-peptide bond conformation that appears to be critical in maintaining the characteristic S-shaped loop. Markedly, the Pro56Ser mutation renders the MSP domain insoluble in buffer. Nevertheless, as facilitated by our recent discovery that "insoluble proteins" can be solubilized in salt-free water, we have successfully characterized the residue-specific conformation of the Pro56Ser mutant by CD and heteronuclear NMR spectroscopy. The Pro56Ser mutant remains lacking of the native tight packing and secondary structures under various conditions and was further characterized as having a non-native helical conformation weakly populated at pH 3.5. Intriguingly, Pro12 located in another S-shaped loop also adopts the cis-peptide bond conformation, and its mutation to Ser is able to make the MSP domain highly insoluble and unfolded like the Pro56Ser mutant. Our study thus implies that the Pro56Ser mutation might lead to ALS by eliminating the native MSP structure, which consequently leads to aggregation and loss of functions under physiological conditions.Keywords
This publication has 65 references indexed in Scilit:
- VAPBNeurology, 2008
- Molecular biology of amyotrophic lateral sclerosis: insights from geneticsNature Reviews Neuroscience, 2006
- A common founder for amyotrophic lateral sclerosis type 8 (ALS8) in the Brazilian populationHuman Genetics, 2005
- Differential Regulation of Endoplasmic Reticulum Structure through VAP-Nir Protein InteractionJournal of Biological Chemistry, 2005
- A Mutation in the Vesicle-Trafficking Protein VAPB Causes Late-Onset Spinal Muscular Atrophy and Amyotrophic Lateral SclerosisThe American Journal of Human Genetics, 2004
- UNRAVELING THE MECHANISMS INVOLVED IN MOTOR NEURON DEGENERATION IN ALSAnnual Review of Neuroscience, 2004
- Mouse VAP33 is associated with the endoplasmic reticulum and microtubulesProceedings of the National Academy of Sciences, 2000
- Erg30, a Vap-33–Related Protein, Functions in Protein Transport Mediated by Copi VesiclesJournal of Cell Biology, 1999
- Molecular Cloning and Characterization of Mammalian Homologues of Vesicle-Associated Membrane Protein-Associated (VAMP-Associated) ProteinsBiochemical and Biophysical Research Communications, 1999
- A VAMP-Binding Protein from Aplysia Required for Neurotransmitter ReleaseScience, 1995